Applied Therapeutics, Inc. (APLT) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -18.4M | -20.34M | -28.64M | -19.47M | -23.33M | -22.59M | -18.91M | -17M | -14.73M | -16.45M | -6.99M | -15.89M |
| Operating CF Margin % | -1840.1% | - | - | - | -19122.95% | -15690.97% | -9953.16% | 2549.48% | - | - | -65.57% | - |
| Operating CF Growth % | 21.13% | 9.98% | -51.43% | -14.49% | -58.43% | -37.34% | -170.54% | -7% | 24.05% | 10.59% | 71.36% | 41.01% |
| Net Income | -18.99M | -21.33M | -21.82M | 44.01M | -68.59M | 2.9M | -83.94M | -37.68M | -42.37M | -29.58M | -10.14M | -14.43M |
| Depreciation & Amortization | 111K | 110K | 104K | 80K | 104K | 122K | 120K | 6K | 118K | 116K | 114K | 114K |
| Stock-Based Compensation | 1.14M | 2.1M | 1.49M | 7.11M | 2.09M | 1.89M | 2.38M | 1.63M | 1.84M | 1.84M | 2.06M | 2M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -41.8M | 27.66M | 14.14M | 0 | 0 |
| Other Non-Cash Items | 2.27M | -1.53M | -3.2M | -76.15M | 40.08M | -22.69M | 63.66M | 59.14M | -121K | -884K | 180K | -3.59M |
| Working Capital Changes | -2.93M | 314K | -5.2M | 5.49M | 2.99M | -4.81M | -1.14M | 1.7M | -1.85M | -2.09M | 798K | 11K |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | -135K | -7K | 435K | 1.6M | 154K | 414K | 527K | -4.26M | 1.32M | -868K | 1.02M | -2.44M |
| Cash from Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 13.87M | -6.91M |
| Capital Expenditures | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | -75K | 0 | 0 | 0 | 0 | -1.69M | 115.5M | 29.45M | 16.57M | 29.15M | -622K | -933K |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | -311K | -465K | -465K | -306K | -622K | -933K |
| Equity Issued (Net) | -1K | 0 | 0 | 0 | 0 | -1000K | 1000K | 1000K | 1000K | 1000K | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | -74K | 0 | 0 | 0 | 0 | 310K | 9.06M | 3K | 10.32M | 1.57M | 0 | 0 |
| Net Change in Cash | -18.48M | -20.34M | -28.64M | -19.47M | -23.33M | -24.29M | 96.59M | 12.44M | 1.84M | 12.7M | 6.26M | -23.73M |
| Free Cash Flow | -18.4M | -20.34M | -28.64M | -19.47M | -23.33M | -22.59M | -18.91M | -17M | -14.73M | -16.45M | -6.99M | -15.89M |
| FCF Margin % | -1840.1% | - | - | - | -19122.95% | -15690.97% | -9953.16% | 2549.48% | - | - | -65.57% | - |
| FCF Growth % | 21.13% | 9.98% | -51.43% | -14.49% | -58.43% | -37.34% | -170.54% | -7% | 24.05% | 10.59% | 71.36% | 41.01% |
| FCF per Share | -0.13 | -0.14 | -0.20 | -0.14 | -0.16 | -0.16 | -0.15 | -0.20 | -0.16 | -0.21 | -0.12 | -0.32 |
| FCF Conversion (FCF/Net Income) | 0.97x | 0.95x | 1.31x | -0.44x | 0.34x | -7.80x | 0.23x | 0.45x | 0.35x | 0.56x | 0.69x | 1.10x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |